Brian C. Stephenson - May 16, 2023 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Secretary, Treasurer & CFO
Signature
/s/ Brian C. Stephenson
Stock symbol
BBIO
Transactions as of
May 16, 2023
Transactions value $
-$632,028
Form type
4
Date filed
5/18/2023, 04:02 PM
Previous filing
May 5, 2023
Next filing
Aug 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Options Exercise +45K +123.59% 81.4K May 16, 2023 Direct F1
transaction BBIO Common Stock Tax liability -$290K -20.6K -25.27% $14.09 60.8K May 16, 2023 Direct F2
transaction BBIO Common Stock Sale -$342K -24.4K -40.15% $14.01 36.4K May 17, 2023 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBIO Restricted Stock Units Options Exercise $0 -1.71K -20% $0.00 6.84K May 16, 2023 Common Stock 1.71K Direct F1, F5
transaction BBIO Restricted Stock Units Options Exercise $0 -778 -12.5% $0.00 5.45K May 16, 2023 Common Stock 778 Direct F1, F6
transaction BBIO Restricted Stock Units Options Exercise $0 -24.2K -25% $0.00 72.6K May 16, 2023 Common Stock 24.2K Direct F1, F7
transaction BBIO Restricted Stock Units Options Exercise $0 -947 -9.1% $0.00 9.47K May 16, 2023 Common Stock 947 Direct F1, F8
transaction BBIO Restricted Stock Units Options Exercise $0 -17.4K -6.25% $0.00 261K May 16, 2023 Common Stock 17.4K Direct F1, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 44,996 shares of Common Stock underlying the Reporting Person's RSUs.
F3 This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 6, 2022.
F4 Represents the weighted average sale price of the shares sold from $13.83 to $14.22 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported herein.
F5 The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F6 The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F7 The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022. Thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F8 The RSUs vest with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/12th of the remaining underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on November 16, 2025, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F9 The RSUs vest with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares shall vest on a quarterly basis, such that all of the underlying shares shall be vested on February 16, 2027, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.